The shareholder correspondence letter from LAHO on
Post# of 27258
(Total Views: 131)
Posted On: 01/19/2021 3:54:53 PM
The shareholder correspondence letter from LAHO on 4/24/2020:
Just as a reminder for everyone to keep their shorts on for now.
(see highlighted area and don't get your shorts in a pretzel)
April 24, 2020
Dear LAHO shareholders.
Lans Management continues to stand by MSSV and the deal we have with them regarding the acquisition of
GSCG. As we are all aware, the COVID-19 pandemic has had a profound impact on the concept of business as
usual and has caused significant challenges and delays. MSSV informed Management that while every effort to
close the acquisition by this weekend had been made, factors outside its control have prevented that goal from
its completion.
The LOI with GSCG has successfully been amended to extend the closing deadline and MSSV has filed an 8K to
that effect. Management is committed to seeing this transaction through and although it is disappointing that
this has been delayed, it is understandable in the context of current prevailing events. Management would like
to reiterate that although the timelines have been moved, nothing else has changed with respect to this
transaction and management expects this transaction to close. As well, Management will keep shareholders
informed as to when the shareholder vote will be scheduled.
It is Management’s continued opinion that MSSV, through the acquisition of Global Stem Cells Group, has the potential to create significant value for Lans shareholders.
Please refer to this section of Lans website for any further communications that may be posted from time to time
by Lans.
Thank you and stay safe.
Just as a reminder for everyone to keep their shorts on for now.
(see highlighted area and don't get your shorts in a pretzel)
April 24, 2020
Dear LAHO shareholders.
Lans Management continues to stand by MSSV and the deal we have with them regarding the acquisition of
GSCG. As we are all aware, the COVID-19 pandemic has had a profound impact on the concept of business as
usual and has caused significant challenges and delays. MSSV informed Management that while every effort to
close the acquisition by this weekend had been made, factors outside its control have prevented that goal from
its completion.
The LOI with GSCG has successfully been amended to extend the closing deadline and MSSV has filed an 8K to
that effect. Management is committed to seeing this transaction through and although it is disappointing that
this has been delayed, it is understandable in the context of current prevailing events. Management would like
to reiterate that although the timelines have been moved, nothing else has changed with respect to this
transaction and management expects this transaction to close. As well, Management will keep shareholders
informed as to when the shareholder vote will be scheduled.
It is Management’s continued opinion that MSSV, through the acquisition of Global Stem Cells Group, has the potential to create significant value for Lans shareholders.
Please refer to this section of Lans website for any further communications that may be posted from time to time
by Lans.
Thank you and stay safe.
(1)
(0)